U.S. Water Utilities Stock News

Goldman Sachs Group (NYSE:GS) has expanded its partnership with Qatar Investment Authority with a preliminary agreement targeting up to $25 billion in investments. The firm has also reorganized its wealth and asset management leadership, elevating seven leaders to its management committee. These moves highlight a focus on international capital partnerships and the role of wealth and asset management within the firm. For investors watching NYSE:GS at a current share price of $940.12, this...

Tilray Medical is rebranding its Italian medical cannabis operations under the Tilray Medical Italia name. The company is expanding pharmaceutical partnerships in Italy to deepen its presence in the regulated medical cannabis market. Tilray Brands (NasdaqGS:TLRY) is broadening its EU-GMP certified product portfolio for distribution through Italian pharmaceutical channels. Tilray Brands, through Tilray Medical, is pushing further into Europe’s regulated medical cannabis market by...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Seanergy Maritime Holdings fair value estimate is US$13.61...

Enterprise Financial Services Corp ( NASDAQ:EFSC ) has announced that it will be increasing its dividend from last...

Levi Strauss (LEVI) closed out FY 2025 with fourth quarter revenue of US$1,765.8 million and basic EPS of US$0.41, setting the tone for a year in which trailing twelve month revenue reached US$6.3 billion and EPS came in at US$1.27. Over the last few quarters, the company has seen revenue move from US$1,443.1 million in Q3 FY 2024 to US$1,749.9 million in Q4 FY 2024 and then to US$1,765.8 million in Q4 FY 2025. Quarterly EPS shifted from US$0.06 to US$0.45 to US$0.41 over the same stretch,...

American Express (AXP) is back in focus after its recent share move. The stock closed at $358.50 as investors weigh its returns profile across the past week, month, and past 3 months. See our latest analysis for American Express. That recent 0.42% 1 day share price gain comes after a softer patch, with the year to date share price return of a 3.82% decline compared with a 1 year total shareholder return of 13.60%. This indicates that longer term momentum has been stronger than the latest...

SLM Corporation (NasdaqGS:SLM) has approved a new $500 million share repurchase program. The company also reported updates on completed buybacks under its existing authorization. SLM released its latest quarterly earnings at the same time, providing fresh insight into its recent performance and capital allocation plans. SLM, trading around $26.92, has posted strong multi-year returns, with the share price up 94.7% over 3 years and 96.0% over 5 years. Over the past year, however, the stock...

Granite Construction announced it has been selected to rehabilitate an eight-mile stretch of U.S. Highway 101 near King City in Monterey County, California, a federally funded infrastructure project valued at about US$20,000,000 and scheduled to run from late first quarter 2026 through first quarter 2027. The project not only adds to Granite’s first quarter capital allocation plan, but also highlights the role of its Coalinga Asphalt Plant in supplying tens of thousands of tons of rubberized...

Why Sprouts Farmers Market stock is getting a closer look Sprouts Farmers Market (SFM) has drawn fresh attention after a stretch of weak share performance, including a 12% decline over the past month and a 55% decline over the past year. For context, the stock last closed at US$70.66. The company reports annual revenue of US$8.65b and net income of US$513.45m. These figures give investors a concrete starting point for assessing the current valuation. See our latest analysis for Sprouts...

Belden (BDC) is drawing investor attention after its recent share performance, with the stock last closing at $119.74 and showing mixed short term returns over the past week, month, and past 3 months. See our latest analysis for Belden. Belden’s recent 1-day share price return of 0.90% sits against a year to date share price return of 1.64%, while the 1-year total shareholder return of 2.01% and 5-year total shareholder return of 140.99% suggest longer term holders have seen stronger momentum...

Cullen/Frost Bankers, Inc. recently reported fourth-quarter and full-year 2025 results showing higher net income and earnings per share versus the prior year, while also detailing lower net charge-offs and confirming both common and preferred stock dividends. Alongside these results, the board completed a prior buyback tranche and authorized a new US$300 million share repurchase program, signaling management’s confidence through continued capital returns. Next, we’ll look at how the stronger...

Monolithic Power Systems, Inc. ( NASDAQ:MPWR ) shares have had a really impressive month, gaining 28% after a shaky...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Viavi Solutions (NasdaqGS:VIAV) announced the launch of the IRINS navigation platform through its Inertial Labs business. The new system is designed to counter spoofing and jamming threats targeting military and critical infrastructure operations. IRINS focuses on assured navigation and continuity of service in mission critical environments. For you as an investor, this launch highlights how Viavi Solutions is leaning into sectors where continuity and resilience are central requirements,...

If you are wondering whether Peloton Interactive's current share price reflects its true value, you are not alone. This article walks through what the numbers are saying about the stock. Peloton's share price recently closed at US$5.73, with returns of a 1.4% decline over 7 days, 8.0% decline over 30 days, 6.4% decline year to date, 29.0% decline over 1 year, 66.3% decline over 3 years, and 96.4% decline over 5 years. These movements may have changed how investors view its risk and...

Relay Therapeutics (RLAY) is back on investors’ radar after a series of analyst upgrades, led by Oppenheimer, tied to interim data for its investigational breast cancer drug zovegalisib and concerns around rival therapy gedatolisib. See our latest analysis for Relay Therapeutics. Relay’s recent analyst upgrades and zovegalisib data arrive after a mixed period for the shares, with a 30 day share price return of a 7.66% decline but a 1 year total shareholder return of 69.82%. This suggests that...

In January 2026, Uniti Group Inc. issued new fixed-income securities, including US$500,000,000 of 8.625% senior notes and US$1 billion of 8.625% senior unsecured notes due 2032 under Regulation S and Rule 144A, with attached guarantees. The completion of these large, guaranteed senior unsecured note offerings materially reshapes Uniti Group’s capital structure and future interest obligations. We’ll now examine how Uniti Group’s sizable 8.625% senior unsecured notes due 2032 may influence...

If you are wondering whether United Natural Foods is attractively priced right now, you are not alone. This article walks through what the current share price might be implying about value. The stock closed at US$37.28, with returns of 8.8% over the past week, 11.3% over the past month, 11.6% year to date and 22.4% over the past year. Over three years the return is a 14.8% decline and over five years the return is 43.1%. Recent share price moves have come alongside ongoing investor interest...

Trustmark (NasdaqGS:TRMK) has reported record full-year earnings, highlighting strong performance across core banking, mortgage banking, and wealth management. The company has raised its quarterly dividend, signaling confidence in its balance sheet and ongoing cash generation. Trustmark also approved a new $100 million stock repurchase program, adding another lever for returning capital to shareholders. At a recent share price of $42.32, Trustmark comes into this news with solid longer term...

Intel Corporation ( NASDAQ:INTC ) shares have had a really impressive month, gaining 30% after a shaky period...

Occidental Petroleum (OXY) has recently drawn investor attention after its shares moved around 1.3% in a single day and about 9.6% over the past month, prompting fresh questions about its current valuation. See our latest analysis for Occidental Petroleum. Those recent share price moves sit against a mixed backdrop, with a 30-day share price return of 9.55% and a year-to-date share price return of 7.17%, but a 1-year total shareholder return of 5.11% decline and a 3-year total shareholder...

In recent days, Catalyst Pharmaceuticals has been highlighted for strong earnings and revenue growth, solid profitability, and a debt-free balance sheet, earning it a spot on an “Affordable Growth” screen. At the same time, upbeat analyst views and collaborations with BioMarin Pharmaceutical and Endo Ventures have reinforced Catalyst’s rare-disease focus as a key differentiator in the biotechnology space. We’ll now examine how Catalyst’s combination of robust financial health and...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Lazard (LAZ) has capped FY 2025 with fourth quarter revenue of US$906.7 million, basic EPS of US$0.50 and net income excluding extra items of US$49.9 million, setting a clear marker for how the year wrapped up. The firm has seen quarterly revenue move from US$811.4 million in Q4 2024 to US$906.7 million in Q4 2025, while Q4 EPS shifted from US$0.89 to US$0.50 over the same stretch, giving investors a mixed read on top line scale and per share profitability as they weigh what softer margins...